People affected with severe acute respiratory syndrome coronavirus 2 can have a wide variety of symptoms. Literature and public discussion forums report persistent symptoms among COVID-19 survivors. More than 25% of COVID-19 survivors report hair loss as a persisting issue. The Centers for Disease Control and Prevention state that hair loss as a potential long-term effect of COVID-19 is currently under investigation. This report may be the first case of hair loss in the patient with postCOVID-19 infection in Saudi Arabia.
{"title":"Post SARS-CoV-2 infection and hair loss","authors":"Fahad K. Alrashidi, Nojoud Alaroush","doi":"10.4103/jdds.jdds_16_21","DOIUrl":"https://doi.org/10.4103/jdds.jdds_16_21","url":null,"abstract":"People affected with severe acute respiratory syndrome coronavirus 2 can have a wide variety of symptoms. Literature and public discussion forums report persistent symptoms among COVID-19 survivors. More than 25% of COVID-19 survivors report hair loss as a persisting issue. The Centers for Disease Control and Prevention state that hair loss as a potential long-term effect of COVID-19 is currently under investigation. This report may be the first case of hair loss in the patient with postCOVID-19 infection in Saudi Arabia.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"128 2","pages":"8 - 10"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91461600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mastocytoma has been reported to appear in close temporal or spatial relationship to intramuscular injection of Hepatitis B vaccine. Here, we report a case of isolated vaccine induced mastocytoma occurring in an 8-month-old female patient.
{"title":"Vaccine induced mastocytoma","authors":"A. Alramthan, L. Ashour, Mohammed Alenezi","doi":"10.4103/jdds.jdds_34_21","DOIUrl":"https://doi.org/10.4103/jdds.jdds_34_21","url":null,"abstract":"Mastocytoma has been reported to appear in close temporal or spatial relationship to intramuscular injection of Hepatitis B vaccine. Here, we report a case of isolated vaccine induced mastocytoma occurring in an 8-month-old female patient.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"7 1","pages":"1 - 2"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83393585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chronic exposure to ultraviolet light causes wrinkles and dyspigmentation. Imiquimod cream is an immune-modulator medication approved for the treatment of genital warts, actinic keratosis, and superficial basal cell carcinoma. Few scientific papers were published in the literature on the effect of imiquimod on photodamaged skin. We report four patients with benign and malignant cutaneous neoplasms who were treated with 5% imiquimod cream and noticed improvement in their skin appearance. We believe that imiquimod cream is a safe and effective option for improving photodamaged skin with excellent safety profile.
{"title":"Imiquimod cream improves photodamaged skin","authors":"Suliman Alfaraj, Y. Ghobara, A. Aleisa","doi":"10.4103/jdds.jdds_39_19","DOIUrl":"https://doi.org/10.4103/jdds.jdds_39_19","url":null,"abstract":"Chronic exposure to ultraviolet light causes wrinkles and dyspigmentation. Imiquimod cream is an immune-modulator medication approved for the treatment of genital warts, actinic keratosis, and superficial basal cell carcinoma. Few scientific papers were published in the literature on the effect of imiquimod on photodamaged skin. We report four patients with benign and malignant cutaneous neoplasms who were treated with 5% imiquimod cream and noticed improvement in their skin appearance. We believe that imiquimod cream is a safe and effective option for improving photodamaged skin with excellent safety profile.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"11 1","pages":"38 - 39"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81075619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Banupriya Mani, A. Priyadarshini, G. Rajesh, A. Sankarasubramanian
Glomus tumor is a benign vascular tumor derived from modified smooth muscle cells of the glomus body. Although they can develop in any part of the body, they commonly do so in the upper extremities, most frequently in the subungual region of fingers. They can be either solitary or multiple. Extradigital glomus tumors are often misdiagnosed owing to their nonspecific clinical presentations and unusual locations. We report two cases of extradigital glomus tumor occurring at unusual sites such as knee and thigh.
{"title":"Glomus tumor presenting as atypical tender papule on the lower limb","authors":"Banupriya Mani, A. Priyadarshini, G. Rajesh, A. Sankarasubramanian","doi":"10.4103/jdds.jdds_58_19","DOIUrl":"https://doi.org/10.4103/jdds.jdds_58_19","url":null,"abstract":"Glomus tumor is a benign vascular tumor derived from modified smooth muscle cells of the glomus body. Although they can develop in any part of the body, they commonly do so in the upper extremities, most frequently in the subungual region of fingers. They can be either solitary or multiple. Extradigital glomus tumors are often misdiagnosed owing to their nonspecific clinical presentations and unusual locations. We report two cases of extradigital glomus tumor occurring at unusual sites such as knee and thigh.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"237 1","pages":"40 - 43"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72653014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yukinori Isozaki, Motoi Kato, N. Fujita, Shota Tojo, M. Fujiki, Azusa Watanabe, Shoji Watanabe
Lymphatic malformation (LM) of the body surface causes symptoms such as bleeding, pain, lymphatic leakage, or infection of the lesion, usually treated with surgical resection and sclerotherapy, with limited efficacy. The vesicles of the body surface tend to recur after surgical resection and may cause lymphatic leakage, which could be long term a burden for patients, eventually decreasing their quality of life. In recent years, the efficacy of orally administered mammalian target of rapamycin inhibitor (rapamycin) has been reported for LM and other vascular anomalies but few are reported in the East Asian population. We report the case of a Japanese female with intractable gluteal LM that was successfully treated with topical rapamycin for postoperative recurrence and hypertrophic scarring.
{"title":"A case of topical rapamycin effective for postsurgical hypertrophic scar of superficial lymphatic malformation with possible quality-of-life improvement","authors":"Yukinori Isozaki, Motoi Kato, N. Fujita, Shota Tojo, M. Fujiki, Azusa Watanabe, Shoji Watanabe","doi":"10.4103/jdds.jdds_38_21","DOIUrl":"https://doi.org/10.4103/jdds.jdds_38_21","url":null,"abstract":"Lymphatic malformation (LM) of the body surface causes symptoms such as bleeding, pain, lymphatic leakage, or infection of the lesion, usually treated with surgical resection and sclerotherapy, with limited efficacy. The vesicles of the body surface tend to recur after surgical resection and may cause lymphatic leakage, which could be long term a burden for patients, eventually decreasing their quality of life. In recent years, the efficacy of orally administered mammalian target of rapamycin inhibitor (rapamycin) has been reported for LM and other vascular anomalies but few are reported in the East Asian population. We report the case of a Japanese female with intractable gluteal LM that was successfully treated with topical rapamycin for postoperative recurrence and hypertrophic scarring.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"5 1","pages":"11 - 14"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86228400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tinea incognita is a phenomenon occurring when a fungal infection is erroneously treated with topical corticosteroids. This worsens the underlying infection without becoming clinically apparent until treatment is withdrawn, in which case the tinea infection becomes acutely symptomatic. We herein report a case of tinea incognita in a young woman treated with high-potency topical corticosteroids, leading to worsening dermatophyte infection and coinfection with Klebsiella oxytoca. The resulting infection required aggressive oral and topical antimicrobial treatment before resolving. This case illustrates the potentially harmful sequelae of using high-potency topical corticosteroids without first ruling out tinea infection.
{"title":"Tinea incognita with secondary bacterial infection","authors":"Daniel A Nadelman","doi":"10.4103/jdds.jdds_22_19","DOIUrl":"https://doi.org/10.4103/jdds.jdds_22_19","url":null,"abstract":"Tinea incognita is a phenomenon occurring when a fungal infection is erroneously treated with topical corticosteroids. This worsens the underlying infection without becoming clinically apparent until treatment is withdrawn, in which case the tinea infection becomes acutely symptomatic. We herein report a case of tinea incognita in a young woman treated with high-potency topical corticosteroids, leading to worsening dermatophyte infection and coinfection with Klebsiella oxytoca. The resulting infection required aggressive oral and topical antimicrobial treatment before resolving. This case illustrates the potentially harmful sequelae of using high-potency topical corticosteroids without first ruling out tinea infection.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"1 1","pages":"26 - 28"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89305054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Nassar, A. Abu-aliat, S. Jamil, Mohammed S Alshahrani, S. Hawwam, Esmat Eid
There is a paucity of literature about human spotted fever rickettsioses (SFR) from the Arab Gulf Region, including Saudi Arabia. Here, we present an elderly Saudi man who had fever, headache, purpuric maculopapular skin rash, and an eschar. Together, the clinical findings, the serologic positivity, the presence of a vector tick in addition to the histopathologic changes, and the dramatic clinical response to oral doxycycline confirmed the diagnosis of SFR. This may be the first case of SFR reported to the health-care authorities in Saudi Arabia. We recommend considering SFR in the differential diagnosis of “fever with purpuric rash” in Saudi Arabia. Ideally, treatment with a tetracycline antibiotic should be considered for patients with fever and headache even before a purpuric rash develops.
{"title":"Spotted fever rickettsioses should be considered in the differential diagnosis of “Fever with Purpuric Rash” in Saudi Arabia: A Case report","authors":"A. Nassar, A. Abu-aliat, S. Jamil, Mohammed S Alshahrani, S. Hawwam, Esmat Eid","doi":"10.4103/jdds.jdds_99_20","DOIUrl":"https://doi.org/10.4103/jdds.jdds_99_20","url":null,"abstract":"There is a paucity of literature about human spotted fever rickettsioses (SFR) from the Arab Gulf Region, including Saudi Arabia. Here, we present an elderly Saudi man who had fever, headache, purpuric maculopapular skin rash, and an eschar. Together, the clinical findings, the serologic positivity, the presence of a vector tick in addition to the histopathologic changes, and the dramatic clinical response to oral doxycycline confirmed the diagnosis of SFR. This may be the first case of SFR reported to the health-care authorities in Saudi Arabia. We recommend considering SFR in the differential diagnosis of “fever with purpuric rash” in Saudi Arabia. Ideally, treatment with a tetracycline antibiotic should be considered for patients with fever and headache even before a purpuric rash develops.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"21 1","pages":"86 - 88"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78787275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Diffuse hair loss is a common complaint in dermatology clinics. Chronic telogen effluvium is a common form of diffuse hair loss. Chronic telogen effluvium is characterized usually by the abrupt onset of diffuse shedding of telogen hairs for more than 6 months. Micronutrients such as Vitamin B 12 are major elements in the normal hair follicle cycle. Vitamin B12 levels in chronic telogen effluvium are not well characterized. Purpose: The aim of this study is to compare Vitamin B12 levels in chronic telogen effluvium patients to controls. Methods: A case–control study was conducted in the department of dermatology of a tertiary care hospital; a total of 70 patients were included, 35 in each group. Results: Twenty-five(71%) chronic telogen effluvium patients were females; 60% had Vitamin B12 deficiency (<250 pg/ml). In controls, fewer (26%) subjects had Vitamin B12 deficiency (P = 0.004). Conclusion: As per our study, Vitamin B12 deficiency was more common in patients with telogen effluvium than in controls.
{"title":"Serum Vitamin B12 in chronic telogen effluvium patients: A case–control study","authors":"P. Mamatha, K. Aparna","doi":"10.4103/jdds.jdds_64_22","DOIUrl":"https://doi.org/10.4103/jdds.jdds_64_22","url":null,"abstract":"Background: Diffuse hair loss is a common complaint in dermatology clinics. Chronic telogen effluvium is a common form of diffuse hair loss. Chronic telogen effluvium is characterized usually by the abrupt onset of diffuse shedding of telogen hairs for more than 6 months. Micronutrients such as Vitamin B 12 are major elements in the normal hair follicle cycle. Vitamin B12 levels in chronic telogen effluvium are not well characterized. Purpose: The aim of this study is to compare Vitamin B12 levels in chronic telogen effluvium patients to controls. Methods: A case–control study was conducted in the department of dermatology of a tertiary care hospital; a total of 70 patients were included, 35 in each group. Results: Twenty-five(71%) chronic telogen effluvium patients were females; 60% had Vitamin B12 deficiency (<250 pg/ml). In controls, fewer (26%) subjects had Vitamin B12 deficiency (P = 0.004). Conclusion: As per our study, Vitamin B12 deficiency was more common in patients with telogen effluvium than in controls.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"22 1","pages":"67 - 69"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83774407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: As COVID-19 vaccines continue to be administered worldwide, there are an increasing number of studies documenting cutaneous reactions following vaccination. Systemic reactions, such as urticarial diseases, occur. Purpose: The main objective of this study was to investigate the association between urticaria and recent vaccination for COVID-19. Methods: A retrospective chart review examining the association of urticaria and COVID vaccination was conducted. Results: We report 17 patients who developed an urticarial reaction following vaccination against COVID and one patient who developed an urticarial reaction following a COVID infection. The vast majority of the patients were women with a mean age of 42.8 years. Conclusion: Cutaneous manifestations often follow COVID vaccination and infection. It may be helpful to inquire about recent infections and vaccinations in patients presenting with urticarial diseases.
{"title":"Delayed-onset urticaria following vaccination for COVID-19","authors":"Brandon Clark, B. Yentzer","doi":"10.4103/jdds.jdds_67_22","DOIUrl":"https://doi.org/10.4103/jdds.jdds_67_22","url":null,"abstract":"Background: As COVID-19 vaccines continue to be administered worldwide, there are an increasing number of studies documenting cutaneous reactions following vaccination. Systemic reactions, such as urticarial diseases, occur. Purpose: The main objective of this study was to investigate the association between urticaria and recent vaccination for COVID-19. Methods: A retrospective chart review examining the association of urticaria and COVID vaccination was conducted. Results: We report 17 patients who developed an urticarial reaction following vaccination against COVID and one patient who developed an urticarial reaction following a COVID infection. The vast majority of the patients were women with a mean age of 42.8 years. Conclusion: Cutaneous manifestations often follow COVID vaccination and infection. It may be helpful to inquire about recent infections and vaccinations in patients presenting with urticarial diseases.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"47 1","pages":"70 - 72"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80987690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eman Almukhadeb, Faisal Alghubaywi, Y. Alharthi, Amer Alharbi
Pityriasis rosea (PR) is frequently proposed to result from a viral etiology. In line with the current pandemic, COVID-19 vaccines are noticed to trigger PR development. Our patient is a 23-year-old female who developed an itchy skin rash following the Pfizer–BioNTech COVID-19 vaccine. Examination showed one erythematous plaque on the left shoulder and multiple small scaly plaques of similar appearance distributed over the trunk and proximal extremities. The patient was clinically diagnosed, educated, reassured, prescribed topical mometasone ointment and oral chlorpheniramine, and was given a follow-up appointment. We report this case to increase awareness on COVID-19 vaccines as potential triggers of PR.
{"title":"Vaccine-induced pityriasis rosea and pityriasis rosea-like Eruptions: A review of literature and a case report of COVID-19 vaccine-induced pityriasis rosea","authors":"Eman Almukhadeb, Faisal Alghubaywi, Y. Alharthi, Amer Alharbi","doi":"10.4103/jdds.jdds_7_22","DOIUrl":"https://doi.org/10.4103/jdds.jdds_7_22","url":null,"abstract":"Pityriasis rosea (PR) is frequently proposed to result from a viral etiology. In line with the current pandemic, COVID-19 vaccines are noticed to trigger PR development. Our patient is a 23-year-old female who developed an itchy skin rash following the Pfizer–BioNTech COVID-19 vaccine. Examination showed one erythematous plaque on the left shoulder and multiple small scaly plaques of similar appearance distributed over the trunk and proximal extremities. The patient was clinically diagnosed, educated, reassured, prescribed topical mometasone ointment and oral chlorpheniramine, and was given a follow-up appointment. We report this case to increase awareness on COVID-19 vaccines as potential triggers of PR.","PeriodicalId":15535,"journal":{"name":"Journal of Dermatology and Dermatologic Surgery","volume":"42 1","pages":"82 - 85"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85779018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：